Suppr超能文献

SF-6Dv2 在伊朗乳腺癌人群中的心理测量特性。

Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population.

机构信息

Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Health Promotion Research Center, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Breast Cancer. 2021 Jul;28(4):937-943. doi: 10.1007/s12282-021-01230-3. Epub 2021 Mar 5.

Abstract

INTRODUCTION

The Short-Form Six-Dimension version 2 (SF-6Dv2) is the newest preference-based instrument for estimation of quality adjusted life-years (QALYs). The aim of this study is to evaluate the validity and reliability of the SF-6Dv2 in an Iranian breast cancer population.

METHODS

The SF-6Dv2 and FACT-B instruments were completed for 416 patients who were recruited from the largest academic center for cancer patients in Iran. The ceiling effects are computed as the proportion of participants reporting no problems in SF-6Dv2 index. Construct validity was evaluated using convergent validity, discriminant validity, and known-groups validity. Reliability was assessed using intra-class correlation coefficient (ICC) and Cohen's kappa value.

RESULTS

The ceiling effects of the SF-6Dv2 was 2.16%. Higher scores of all subscales of the FACT-B were associated with patients who reported no problems in each of the SF-6Dv2 dimensions. The correlation between SF-6Dv2 dimensions and FACT-B subscales varied from 0.109 between the role limitation of the SF-6Dv2 and the SWB subscale of the FACT-B to 0.665 between the pain dimension of SF-6Dv2 and the PWB of FACT-B. The lower mean score of SF-6Dv2 was associated with patients with older age, higher education level, more severe current treatment status, and more severe cancer stage status. ICC for the SF-6Dv2 index scores was 0.66, and Kappa values varied from 0.33 for mobility to 0.66 for mental health dimensions.

CONCLUSIONS

The validity and reliability of the SF-6Dv2 were satisfaction in a breast cancer population and it can be employed in clinical practice or research.

摘要

简介

简表六维度版本 2(SF-6Dv2)是最新的用于估计质量调整生命年(QALYs)的基于偏好的工具。本研究旨在评估 SF-6Dv2 在伊朗乳腺癌人群中的有效性和可靠性。

方法

从伊朗最大的癌症患者学术中心招募了 416 名患者,完成了 SF-6Dv2 和 FACT-B 量表。计算了 SF-6Dv2 指数中无问题报告者的比例作为天花板效应。采用收敛有效性、判别有效性和已知群体有效性来评估结构有效性。采用组内相关系数(ICC)和 Cohen's kappa 值评估可靠性。

结果

SF-6Dv2 的天花板效应为 2.16%。FACT-B 各子量表的得分越高,报告 SF-6Dv2 各维度无问题的患者比例越高。SF-6Dv2 维度与 FACT-B 子量表之间的相关性从 SF-6Dv2 角色限制与 FACT-B 的 SWB 子量表之间的 0.109 到 SF-6Dv2 的疼痛维度与 FACT-B 的 PWB 之间的 0.665 不等。SF-6Dv2 得分较低与患者年龄较大、教育程度较高、当前治疗状况较严重、癌症分期较严重有关。SF-6Dv2 指数得分的 ICC 为 0.66,Kappa 值从移动性的 0.33 到心理健康维度的 0.66 不等。

结论

SF-6Dv2 在乳腺癌人群中的有效性和可靠性令人满意,可用于临床实践或研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验